Previous 10 | Next 10 |
2024-02-15 23:53:08 ET Prothena Corporation plc (PRTA) Q4 2023 Earnings Conference Call February 15, 2023 4:30 PM ET Company Participants Mark Johnson - Vice President of Investor Relations Gene Kinney - President and Chief Executive Officer Hideki Garren - Chief...
2024-02-15 16:27:16 ET More on Prothena Prothena: Upcoming Alzheimer's Data Could Solidify Its Position In The Market Prothena stock falls as Bank of America downgrades on program delays Prothena stock tumbles 23% in premarket trading Seeking Alpha’s Q...
Net cash used in operating and investing activities was $52.6 million in the fourth quarter and $136.7 million for the full year of 2023; quarter-end cash and restricted cash position was $621.0 million The company expects cash guidance for the full year 2024 net cash used in operating and in...
Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that it will report its fourth quarter and full year 2023 financial results on Thursday, February 15...
A look at the top 10 most actives in the United States Connexa Sports Technologies Inc. (CNXA) rose 101.2% to $0.4 on volume of 236,162,112 shares PROSHARES TRUST (SQQQ) rose 5.9% to $12.78 on volume of 177,226,563 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 4.5% to $5....
2024-01-30 11:05:09 ET More on Prothena Prothena: Upcoming Alzheimer's Data Could Solidify Its Position In The Market Prothena stock tumbles 23% in premarket trading Seeking Alpha’s Quant Rating on Prothena Historical earnings data for Prothena ...
2024-01-09 15:45:01 ET JMP Securities analyst issues MARKET OUTPERFORM recommendation for PRTA on January 9, 2024 04:00PM ET. The previous analyst recommendation was Market Outperform. PRTA was trading at $39.62 at issue of the analyst recommendation. The overall analyst...
2024-01-08 12:31:25 ET Gainers: Harpoon Therapeutics ( HARP ) +112% . Ambrx Biopharma ( AMAM ) +101% . Nkarta ( NKTX ) +47% . Mountain Crest Acquisition Corp IV ( MCAF ) +45% . Spectaire Holdings ( SPEC ) +43% . Neximmune ( ...
2024-01-08 10:00:05 ET More on Health Care Select Sector SPDR XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Covid-vaccine makers top laggard list, LLY and WST top gainers list Healthcare and uti...
2024-01-08 09:29:35 ET More on Prothena Prothena: Upcoming Alzheimer's Data Could Solidify Its Position In The Market Prothena, BioVie among decliners after Biogen data for new Alzheimer’s therapy Prothena jumps on report company may explore a potential sale ...
News, Short Squeeze, Breakout and More Instantly...
Prothena Corporation plc Company Name:
PRTA Stock Symbol:
NASDAQ Market:
2024-05-03 17:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that it will report its first quarter 2024 financial results on Wednesday, May 8, 2024, after the cl...
2024-04-23 23:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...